Mr. Yoon joined BI – Seoul in 2015 as Associate Director, Brand Development and was promoted to President in 2018. Mr. Yoon was promoted to Divisional President, Asia, Seoul in 2019. Prior to Brand Institute, Mr. Yoon was a Global Regulatory Affairs Manager at Daewoong Pharmaceutical and a Licensing & Business Development Manager at Kukje Pharmaceuticals. Mr. Yoon earned his B.S in Genetics, PGDipSci and Bachelor of Pharmacy from the University of Otago. He is a registered Pharmacist in Australia and New Zealand. He has led over 70 Nonproprietary (USAN/INN) projects, including efineptakin alfa, fexuprazan, rivoceranib, and timbetasin, and 52 Global Brand Naming projects, highlighted by Celltrion’s biosimilar brands Yuflyma, Remsima, Herzuma and Truxima.
